业务
货币单位:美元
2024/Q2
名称营收比例
Coronavirus disease 2019 (COVID-19)1,893.9万34.86%
Human immunodeficiency virus (HIV)1,365.2万25.13%
Molecular Sample Management Solutions1,260.9万23.21%
Hepatitis C virus (HCV)473.4万8.71%
Risk assessment testing230.8万4.25%
Other product and service revenues89.7万1.65%
Molecular Services81万1.49%
Non-product and services revenues38.6万0.71%
查看全部
地区
货币单位:美元
2023/FY
名称营收比例
美国3.62亿89.19%
其他地区3,570.1万8.80%
欧洲811.1万2.00%
